Goldman Sachs
ERNA icon

Goldman Sachs’s Eterna Therapeutics ERNA Stock Holding History

Goldman Sachs’s Portfolio ERNA Stock Details ERNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.31K Buy
+665
New +$10.6K ﹤0.01% 6411
2025
Q2 		– Sell
-48
Closed -$3.21K – 6169
2025
Q1 		$3.21K Buy
48
+14
+41% +$1.73K ﹤0.01% 5999
2024
Q4 		$3.77K Buy
+34
New +$9.22K ﹤0.01% 5960
2023
Q3 		– Sell
-30
Closed -$25.5K – 5633
2023
Q2 		$25.5K Buy
+30
New +$30.3K ﹤0.01% 5528
2022
Q4 		– Sell
-10
Closed -$19K – 6054
2022
Q3 		$19K Sell
10
-3
-23% -$10.3K ﹤0.01% 5948
2022
Q2 		$48K Buy
13
+8
+160% +$57.4K ﹤0.01% 6033
2022
Q1 		$79K Sell
5
-4
-44% -$75.9K ﹤0.01% 6171
2021
Q4 		$293K Buy
9
+6
+200% +$326K ﹤0.01% 5681
2021
Q3 		$182K Buy
+3
New +$259K ﹤0.01% 5754
2017
Q1 		– Sell
-1
Closed -$112K – 6821
2016
Q4 		$112K Hold
1
– – ﹤0.01% 6086
2016
Q3 		$123K Hold
1
– – ﹤0.01% 6127
2016
Q2 		$192K Buy
+1
New +$113K ﹤0.01% 5717
2016
Q1 		– Hold
0
– – – 6695
2015
Q4 		– Hold
0
– – – 6890
2015
Q3 		– Hold
0
– – – 6912
2015
Q2 		– Hold
0
– – – 7056
2015
Q1 		– Hold
0
– – – 6742
2014
Q4 		– Hold
0
– – – 6841
2014
Q3 		– Hold
0
– – – 6907
2014
Q2 		– Hold
0
– – – 6734
2014
Q1 		– Hold
0
– – – 6647
2013
Q4 		– Hold
0
– – – 6595

Other funds holding ERNA

BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
DIG
Dauntless Investment Group Etna, New Hampshire $151M AUM 76.14% 1-Year Est. Return
Corient Private Wealth
Corient Private Wealth Miami, Florida $69.9B AUM 22.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
WAM
Warberg Asset Management Winnetka, Illinois $600M AUM 23.37% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

Goldman Sachs's ERNA Position: Q1 2026 in Review

Goldman Sachs opened a new position in Eterna Therapeutics (ERNA) in Q1 2026: 665 shares worth $3.31K. The stake represents ﹤0.01% of the portfolio and ranks #6411 among its holdings. This is a return to the name: Goldman Sachs previously reported a position in ERNA as recently as Q1 2025.

Goldman Sachs first reported a position in ERNA in Q2 2016 and has held it in 12 quarters since. The position peaked at $293K in Q4 2021. 15 funds tracked by Wall St. Rank hold ERNA as of Q1 2026.

  • Goldman Sachs held 665 shares of Eterna Therapeutics worth $3.31K as of Q1 2026.
  • Eterna Therapeutics was a new Goldman Sachs position in Q1 2026.
  • Eterna Therapeutics made up ﹤0.01% of Goldman Sachs's portfolio in Q1 2026, its #6411 holding.
  • Goldman Sachs first reported a position in Eterna Therapeutics in Q2 2016 and has held it in 12 quarters since.
  • Goldman Sachs's Eterna Therapeutics position peaked at $293K in Q4 2021.
  • 15 funds tracked by Wall St. Rank held Eterna Therapeutics as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.